Portland — Portland, Oregon

Portland is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Portland has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Sponsors: Finch Research and Development LLC., Corcept Therapeutics, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Portland?

Portland has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Portland conducted?

Portland has 5 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Is Portland accredited by Crixeo Clinical Trials?

Portland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Portland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.